Abstract 5531: PD-1 blockades plus targeted therapy and cytotoxic drugs as conversion therapy in unresectable metastatic colorectal cancer (mCRC): A real-world experience
Authors: Ling Huang, Liying Zhao, Xinyi Liu, Mengli Huang
Published: 2022-06-15
DOI:
10.1158/1538-7445.am2022-5531
Source:
Full article
Abstract
Abstract